2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoic Acid CAS 178306-51-9 Maʻemaʻe ≥99.0% (HPLC) Kiʻi Hōʻike ʻia o ka Hale Hana

2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoic Acid CAS 178306-51-9 Maʻemaʻe ≥99.0% (HPLC) Hale Hana

ʻO ka wehewehe pōkole:

Inoa: 2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoic Acid

CAS: 178306-51-9

ʻAno: Pahu keʻokeʻo a i ʻole keʻokeʻo

Maʻemaʻe: ≥99.0% (HPLC)

Ka waena o (CAS: 177036-94-1) i ka mālama ʻana i ka Pulmonary Arterial Hypertension (PAH)

Inquiry: alvin@ruifuchem.com

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Hoʻolako Kalepa (CAS: 177036-94-1) Nā Kūwaena Pili:
CAS: 177036-94-1
Methyl 2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoate CAS: 178306-47-3
2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoic Acid CAS: 178306-51-9
(S)-2-Hydroxy-3-Methoxy-3,3-Diphenylpropionic Acid CAS: 178306-52-0
L-Proline Methyl Ester Hydrochlorid CAS: 2133-40-6
4,6-Dimethyl-2-(Methylsulfonyl)pyrimidine CAS: 35144-22-0

Na Waiwai Kemika:

Inoa Kimia	2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoic Acid
Helu CAS	178306-51-9
Helu CAT	RF-PI161
Kūlana Kūʻai	Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā tona
ʻĀpana Molekala	C16H16O4
Kaumaha Molecular	272.3
ʻO ka mānoanoa	1.248
Brand	ʻO Ruifu Chemical

Nā kikoʻī:

'ikamu	Nā kikoʻī
Ka nana aku	Pada keʻokeʻo a i ʻole keʻokeʻo
Maemae	≥99.0% (HPLC)
Māmā (KF)	≤1.00%
Hoʻokahi haumia	≤0.50%
Huina paumaele	≤1.00%
Kūlana hoʻāʻo	ʻOihana Kūlana
Hoʻohana	Waena o API (CAS: 177036-94-1)

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻO ka'ōmole, Aluminum foil eke, 25kg/Drum, aiʻole e like me ka makemake o ka mea kūʻai

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai

Pono:

FAQ:

Noi:

ʻO Shanghai Ruifu Chemical Co., Ltd. ka mea hana alakaʻi a me ka mea hoʻolako o 2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoic Acid (CAS: 178306-51-9) me ke kūlana kiʻekiʻe, he kī waena ia o API (CAS : 177036-94-1).(CAS: 177036-94-1)he endothelin-A (ETA) receptor antagonist i hoʻokomo ʻia no ka mālama waha ʻana i nā maʻi me ka pulmonary arterial hypertension (PAH), e hoʻomaikaʻi i ka hiki ke hoʻoikaika a hoʻopaneʻe i ka hoʻonui ʻana i ke kino.ʻO ia ke kolu o ka ET-receptor antagonist e kūʻai ʻia no kēia hōʻailona ma hope o bosentan a me sitaxsentan.ʻO ka PAH he maʻi kakaʻikahi o nā aʻaʻaʻa liʻiliʻi liʻiliʻi i hōʻike ʻia e ka hoʻonui ʻana a me ka hoʻoponopono hou ʻana, e hopena i ka piʻi ʻana o ke kūpaʻa ʻana o ka pulmonary vascular a me ke kaomi ʻana o ka pulmonary arterial, a ʻo ka hopena, ʻaʻole hiki i ka ventricular akau a me ka make mua.ʻO nā hōʻailona mua o ka PAH e pili ana i ka hoʻomaka mālie o ka hanu, ka luhi, ka palpitation, ka edema, a me ka maule.